Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib
出版年份 2011 全文链接
标题
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib
作者
关键词
-
出版物
LEUKEMIA
Volume 26, Issue 5, Pages 985-990
出版商
Springer Nature
发表日期
2011-12-20
DOI
10.1038/leu.2011.360
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease
- (2011) J.-C. Chomel et al. BLOOD
- FGFR3 Is Overexpressed Waldenstrom Macroglobulinemia and Its Inhibition by Dovitinib Induces Apoptosis and Overcomes Stroma-Induced Proliferation
- (2011) A. K. Azab et al. CLINICAL CANCER RESEARCH
- Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis
- (2010) F. Vianello et al. HAEMATOLOGICA
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Smac mimetics: implications for enhancement of targeted therapies in leukemia
- (2010) E Weisberg et al. LEUKEMIA
- RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma
- (2009) A. K. Azab et al. BLOOD
- CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
- (2009) A. K. Azab et al. BLOOD
- Impact of CXCR4 inhibition on FLT3-ITD−positive human AML blasts
- (2009) Angela Jacobi et al. EXPERIMENTAL HEMATOLOGY
- Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+cell to Imatinib and Nilotinib
- (2009) Falk Dillmann et al. LEUKEMIA & LYMPHOMA
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
- (2009) I. Kalatskaya et al. MOLECULAR PHARMACOLOGY
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
- Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors
- (2008) H Konig et al. LEUKEMIA
- Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
- (2008) E. Weisberg et al. MOLECULAR CANCER THERAPEUTICS
- CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells
- (2008) L. Jin et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started